Ahren Innovation Capital
VC Fund
London, United Kingdom
Ahren Innovation Capital is an investment institution that supports transformational companies at the intersection of deep tech and deep science that will penetrate, or create, massive markets. Ahren is a unique partnership of investment talent and best-in-class commercial scientists whose technologies are today valued in excess of $100BNcombined.Ahren believes in taking asymmetric, considered, risk that will deliver superior rewards – capturing a generational opportunity to provide smart capital to deep technology.With a philosophy espousing the importance of relationships and trust, Ahren provides both patient and active capital to exceptional founders and teams, empowering them to succeed.
- Total investments:
- 46
- Last investment:
- Lead investor:
- 39%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Ahren Innovation Capital invests in
Stages Ahren Innovation Capital invests in
Countries Ahren Innovation Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 13 contacts → | |||
Round size
- Seed
- $2.7M–$8.5M
- Series A
- $10M–$58M
- Series B
- $15M–$150M
Investment Focus
Industry
- Biotechnology 9 (20%)
- Artificial Intelligence 9 (20%)
- Machine Learning 6 (13%)
- Health Care 5 (11%)
- Information Technology 5 (11%)
Stage
- Series A 11 (24%)
- Seed 10 (22%)
- Series B 6 (13%)
- Series D 3 (7%)
- Pre-Seed 2 (4%)
Country
- United Kingdom 12 (26%)
- United States 10 (22%)
- Israel 3 (7%)
- Germany 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alice Newcombe-Ellis
Founding & General Partner
|
Founding & General Partner | Total investments: 12 | Find email | |
Andy Parker
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
Anuj Nanwani
Investment Director
|
Investment Director | Total investments: 0 | Find email | |
Gregory Winter
Founding Partner
|
Founding Partner | Total investments: 2 | Find email | |
Joanna Green
principal
|
principal | Total investments: 2 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CodiKoat is a manufacturing company that develops products using nanotechnology to inactivate viruses and bacteria. | $11M / Series A / Feb 03, 2026 | ||
| A biotechnology company developing AI-driven genomic foundation models | $8M / Seed / Nov 20, 2025 | ||
| Building an automated algorithm discovery agent through program synthesis, solving the enterprise “algorithmic bottleneck” that limits efficiency and scalability. The company’s platform combines large language models with symbolic systems to autonomously find the most optimal algorithms for a given task. | $5M / Seed / Sep 16, 2025 | ||
| Bitfount is an all-in-one platform for federated data science and AI, enabling powerful data collaborations between organisations without any data sharing, and including a range of built-in privacy-enhancing technologies (PETs). | $8M / Series A / Jul 23, 2025 | ||
| OutSee creates cutting-edge computational methods for genomics for the development of therapeutic targets and precision medicine. | $3.4M / Seed / Jun 24, 2025 | ||
| AI21 Labs is a creator of generative artificial intelligence and massive language models, as well as tools for creating artificial intelligence systems with extraordinary understanding and generation of natural language. The company's tool captures real intelligence and rewrites writing to say exactly what is meant; it transforms the waypeople read and write, empowering them in the process; it is an artificial intelligence-based writing companion that understands context and meaning; and it helps people read more efficiently by providing summaries, allowing customers to understand, analyze, and visualize abstract knowledge structures. | $300M / Series D / May 11, 2025 | ||
| Ovo Labs is developing therapeutics that boost egg quality to enhance IVF success, technology aims to extend the timeline when the chances of conception are high. | $5.3M / Seed / Apr 24, 2025 | ||
| Heirloom is a provider of direct air capture technology to enhance the natural process of CO2 absorption from the atmosphere. Its technology accelerates limestone's ability to capture carbon dioxide, storing it permanently underground while operating with renewable energy. | $150M / Series B / Dec 04, 2024 | ||
| Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things. | $57.7M / Series A / Sep 24, 2024 | ||
| ZOE is a personalized nutrition company that operates the world's largest nutrition-science study, as well as the ZOE Health Study (formerly ZOE COVID Study). It improves the health of millions by utilizing data on a previously unimagined scale and unraveling the complex relationship between food, lifestyle, and health. The ZOE program beginswith an at-home test and provides members with personalized advice on how to eat for their bodies and long-term health.Its science is based on the realization that everyone reacts differently to food and that gut bacteria play an important role in health. ZOE research has been published in peer-reviewed journals such as Nature Medicine, Nature Metabolism, The Lancet, Gut, and others. | $15M / Series B / Jul 29, 2024 | ||
| See all 46 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ahren Innovation Capital invest in?
Ahren Innovation Capital invests primarily in Biotechnology, Artificial Intelligence and Machine Learning startups, most often at Series A and Seed stage. Most of the 46 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ahren Innovation Capital's check size?
Ahren Innovation Capital typically joins rounds of $2.7M–$8.5M at Seed, $10M–$58M at Series A and $15M–$150M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ahren Innovation Capital participates in.
How do I contact Ahren Innovation Capital?
Public channels for Ahren Innovation Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ahren Innovation Capital?
The team at Ahren Innovation Capital includes Alice Newcombe-Ellis (Founding & General Partner), Andy Parker (Founding Partner) and Anuj Nanwani (Investment Director), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
